Neurologiske hændelser I behandlingsperioden fik fire patienter (2%) i R- CHOP- armen, alle med kardiovaskulære risikofaktorer, tromboemboliske cerebrovaskulære hændelser i den første behandlingsserie.
Neurologic events During the treatment period, four patients (2%) treated with R-CHOP, all with cardiovascular risk factors, experienced thromboembolic cerebrovascular accidents during the first treatment cycle.